A Study of the Safety, Tolerability, and Pharmacokinetics of Orally Administered Venglustat and Itraconazole in Healthy Adult Male Participants
Completed · Phase 1
Conditions studied: Healthy Volunteers
In brief
The purpose of this study is to assess in healthy adult male participants the effects of itraconazole on the pharmacokinetics of venglustat and to assess the safety and tolerability of venglustat with and without coadministration of itraconazole. The maximum duration for participants from screening is between 32 to 62 days.
Key facts
- Study ID
- NCT06421714
- Run by
- Genzyme, a Sanofi Company
- People needed
- 8
- Starts
- 2018-08-16
- Expected to finish
- 2018-10-14
- Last updated by the study team
- 2024-05-20
Who can join
Age: 18 and older, up to 55. Sex: male. Healthy volunteers: accepted.
Where it is running
- PPD — Austin, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.